Intrinsiqq
Trupanion Inc. logo

Trupanion Inc. (TRUP) Insider Trading

Last 12 months

Insiders sold $2.94M and bought nothing on the open market.

80% of the selling was scheduled in advance under 10b5-1 plans. Chief Revenue Officer Emily Dreyer sold $219k on Mar 4, 18% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2024.

Net open-market
−$2.94M
0 buys · 27 sales
Under a 10b5-1 plan
80%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
May 2024
May 7, 2024

Get an email when TRUP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 910b5-1 plan
    Margaret Tooth
    CEO · sold 1,000 at $25.84
    $26k
    0.5% of stake
  • Sep 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 431 at $22.92
    $10k
    1.3% of stake
  • Sep 1110b5-1 plan
    Margaret Tooth
    CEO · sold 1,000 at $25.00
    $25k
    0.5% of stake
  • Aug 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 3,604 at $29.70
    $107k
    9.7% of stake
  • Aug 26No plan
    Fawwad Qureshi
    Chief Financial Officer · sold 6,111 at $30.01
    $183k
    59% of stake
  • Aug 25No plan
    Margaret Tooth
    CEO · sold 491 at $31.84
    $16k
    0.3% of stake
  • Aug 1110b5-1 plan
    Margaret Tooth
    CEO · sold 978 at $29.05
    $28k
    0.6% of stake
  • Jul 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 431 at $25.08
    $11k
    1.3% of stake
  • Jun 2910b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 431 at $25.35
    $11k
    1.3% of stake
  • Jun 5No plan
    Steve Weinrauch
    EVP, North Am & Vet Strategy · sold 6,674 at $22.00
    $147k
    7.9% of stake
  • May 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 3,603 at $21.69
    $78k
    9.8% of stake
  • May 2710b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 6,177 at avg $22.18
    $137k
    75% of stake
  • May 25No plan
    Margaret Tooth
    CEO · sold 491 at $21.86
    $11k
    0.3% of stake
  • Apr 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 431 at $27.47
    $12k
    1.3% of stake
  • Mar 3010b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 430 at $25.47
    $11k
    1.3% of stake
  • Mar 4No plan
    Emily Dreyer
    Chief Revenue Officer · sold 7,792 at $28.15
    $219k
    18% of stake
  • Feb 2710b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 2,837 at $26.46
    $75k
    100% of stake
  • Feb 2710b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 5,283 at $26.52
    $140k
    14% of stake
  • Feb 2510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 4,645 at $25.61
    $119k
    62% of stake
  • Feb 25No plan
    Steve Weinrauch
    EVP, North Am & Vet Strategy · sold 85 at $26.70
    $2k
    0.1% of stake
  • Jan 2810b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 430 at $31.67
    $14k
    1.3% of stake
  • Dec 29, 202510b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 430 at $37.55
    $16k
    1.3% of stake
  • Dec 19, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 9,605 at avg $37.89
    $364k
    6.0% of stake
  • Nov 28, 202510b5-1 plan
    John R Gallagher
    Chief Operating Officer · sold 6,383 at $34.82
    $222k
    16% of stake
  • Nov 26, 202510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 6,202 at $35.45
    $220k
    100% of stake
  • Nov 25, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 9,803 at avg $35.31
    $346k
    6.1% of stake
  • Oct 27, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 8,884 at avg $43.73
    $388k
    5.9% of stake
  • Sep 25, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 2,961 at $41.88
    $124k
    2.0% of stake
  • Sep 3, 2025 – Sep 4, 2025No plan
    Darryl Rawlings
    Director · sold 50,000 at avg $44.74
    $2.24M
    3.4% of stake
  • Sep 2, 202510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 6,451 at $45.15
    $291k
    100% of stake
  • Aug 26, 202510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 2,800 at $45.56
    $128k
    30% of stake
  • Jun 6, 2025No plan
    Margaret Tooth
    CEO · sold 200 at $48.57
    $10k
    0.2% of stake
  • Jun 2, 2025No plan
    Brenna McGibney
    Chief Administration Officer · sold 2,390 at $45.17
    $108k
    41% of stake
  • May 29, 202510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 2,534 at $48.31
    $122k
    42% of stake
  • May 29, 2025No plan
    John R Gallagher
    Chief Operating Officer · sold 4,000 at $47.90
    $192k
    13% of stake
  • May 27, 202510b5-1 plan
    Fawwad Qureshi
    Chief Financial Officer · sold 828 at $45.53
    $38k
    12% of stake
  • May 20, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 4,000 at $45.86
    $183k
    3.3% of stake
  • May 19, 2025No plan
    Brenna McGibney
    Chief Administration Officer · sold 2,421 at $45.81
    $111k
    65% of stake
  • Apr 21, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 4,000 at $33.34
    $133k
    3.3% of stake
  • Mar 20, 202510b5-1 plan
    Margaret Tooth
    CEO · sold 4,000 at $37.18
    $149k
    3.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TRUP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

Spot a number that looks wrong? Check it in TRUP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TRUP

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.